EARLYSTRAND
LIVE

Serial Number

98285962

Owner

Linus Biotechnology Inc.

Attorney

Michael R. Rizzo

Filing Date

Nov 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EARLYSTRAND Trademark

Serial Number: 98285962

EARLYSTRAND is a trademark filed by Linus Biotechnology Inc. on November 27, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Linus Biotechnology Inc. (5 trademarks)

83 Woodlawn Avenue
New Rochelle, NY 10804

Entity Type: 03

Trademark Details

Filing Date

November 27, 2023

Registration Date

Not Registered

Published for Opposition

July 30, 2024

Goods & Services

Laboratory diagnostic kits comprised of a test tube for specimen collection and a requisition form for use with an analysis device for testing hair samples for diagnosis of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer

Medical diagnostic kits comprising medical diagnostic reagents to be used in exposomic testing; medical diagnostic kits comprising medical diagnostic reagents for diagnosing autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical diagnostic reagents and assays for testing hair samples

Medical diagnostic testing, monitoring and reporting services; medical testing for diagnostic purposes in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; genetic testing for medical purposes

Medical and scientific research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer diagnosis; medical research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer treatment and diagnosis; laboratory research in the fields of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; genetic testing for scientific research purposes

Apparatus for exposomic testing for medical purposes; apparatus for analysis of hair samples for medical diagnostic purposes for detecting autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing for detecting autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical devices for testing hair samples for diagnostic purposes for detecting autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer; medical diagnostic kits comprised of blood collecting, urine collecting, and hair sample collecting tubes for specimen collection and a requisition form for use with an analysis device for testing hair samples for diagnosis of autism spectrum disorder (ASD), attention deficit hyperactive disorder (ADHD), amyotrophic lateral sclerosis (ALS), psychosis, schizophrenia, inflammatory bowel disease (IBS), eosinophilic esophagitis, renal disease, and cancer

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 27, 2026 EXRA
SOU EXTENSION 3 GRANTED
Feb 26, 2026 EX3G
SOU EXTENSION 3 FILED
Feb 26, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 26, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 28, 2025 EXRA
SOU EXTENSION 2 GRANTED
Sep 16, 2025 EX2G
SOU EXTENSION 2 FILED
Sep 16, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 16, 2025 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 21, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 21, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 21, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 21, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 21, 2025 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 6, 2025 EXRA
SOU EXTENSION 1 GRANTED
Mar 5, 2025 EX1G
SOU EXTENSION 1 FILED
Mar 5, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 5, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 24, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 30, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 30, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 10, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 26, 2024 CNSA
ASSIGNED TO EXAMINER
Jun 26, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 17, 2024 NWOS
NEW APPLICATION ENTERED
Nov 30, 2023 NWAP